INTRODUCTION
From extensive studies of the inhibition of mitochondrial respiration and phosphorylation, it has been inferred that guanidine derivatives bind to energy conservation sites in mitochondria, the major functional locus of binding depending upon the structure of the guanidine compound (1). The modifications of structure which enhance the inhibitory potency of the guanidine derivatives and alter site-binding specificity are alterations in the nonpolar hydrocarbon side chain, a fact which has suggested that binding depends in large part on nonpolar interactions with mitochondrial con-stituents. The inhibitory effects of these agents can be reversed by various uncoupling agents which are also lipophilic in nature (2), a finding which lends further support to the inference that both groups of compounds operate at loci in a relatively nonpolar environment.
It was of particular interest, therefore, to find that the inhibitory potency of phenethylbiguanide on mitochondrial preparations in vitro could be strikingly enhanced by the presence of low concentrations of fatty acid-free serum albumin (3) , bringing the effective inhibitory concentrations of phenethylbiguanide in vitro into the range which is effective in producing hypoglycemia in vivo. As suggested in the previous paper, this effect of albumin may reasonably be ascribed, at least in part, to the binding and removal from the mitochondrion of endogenously generated mitochondrial free fatty acids (4, 5) . The present paper presents further evidence to support the antagonism between both endogenous and exogenous long chain free fatty acids and guanidine derivatives. The interaction of free fatty acids with mitochondria under the special conditions of these experiments has been characterized in some detail and appears to involve binding to relatively specific mitochondrial sites. Binding of phenethylbiguanide to mitochondria has also been examined directly and found to be affected by the presence of free fatty acid. The mechanism whereby this bound fatty acid interferes with the inhibitory action of guanidine derivatives differs significantly 2344 The Journal of Clinical Investigation Volume 47 1968 from dinitrophenol-induced reversal of guanidinederivative inhibition.
METHODS
Individual fatty acids were obtained from Applied Science Laboratories, Inc., State College, Pa., Fisher Scientific Company, Pittsburgh, Pa., and Calbiochem, Los Angeles, Calif. They were analyzed as the methyl esters by gas-liquid chromatography and contained less than 5% of other fatty acid impurities. Decamethylene diguanidine (DDG) carbonate was obtained from K & K Laboratories, Inc., Plainview, N. Y., galegine sulfate and guanidine HCO from Calbiochem, phenethylbiguanide and dimethylbiguanide (DMB) from Aldrich Chemical Co., Inc., Milwaukee, Wis. Radiochemicals were obtained from New England Nuclear Corp., Boston, Mass. and were stored as previously described (3) . Fatty acid-free bovine serum albumin (BSA) and fatty acid albumin complexes were prepared as described in the accompanying paper (3) . Phenthylbiguanide-'H was prepared by catalytic exchange tritiation, and the product was purified by preparative paper chromatography. The resultant product was radiochromatographically homogenous in two different solvent systems on paper (6) .
Incubation procedures. Preparation of mitochondria, incubations, measurement of respiration, and collection and counting of '4CO2 were carried out as described in the accompanying paper (3) . P: 0 ratios were determined by stopping the reaction with 0.1 ml of 25% trichloroacetic acid, centrifuging off the precipitated protein, and assaying an aliquot of the supernatant for inorganic phosphate (7) . Control incubations were carried out to determine the amount of inorganic phosphate present at zero time. P: 0 ratios were calculated by dividing the phosphate esterified, in micromoles, determined as the difference between zero time and final inorganic phosphate, by the amount of oxygen consumed, in microatoms.
Fatty acids were added to the reaction mixture as the fatty acid: albumin complex usually 7: 1, prepared as described in the preceding paper (3) .
Binding of fatty acids to mitochondria was measured directly by incubating mitochondria with '4C-labeled fatty acids of known specific activity complexed to albumin. At appropriate time intervals, aliquots of the incubation mixture were placed in chilled centrifuge tubes and spun at 12,000 g for 3 min. Since bound fatty acids are not removed by washing mitochondria in the absence of serum albumin (4), the supernatant was removed, and the mitochondrial pellet washed twice by resuspension in sucrose-ethylenediaminetetraacetate (EDTA) -KC1 buffer, followed by centrifugation. Control experiments indicated that less than 10%o of the radioactivity remaining after two washings was removed by further washings. The mitochondrial pellet was then dissolved in a small quantity of Hyamine hydroxide base (p-[diisobutylcresoxy-ethoxyethyl]-dimethylbenzyl ammonium hydroxide), the mixture taken up in scintillator solution (3) , and radioactivity determined in a scintillation spectrometer with corrections for quenching.
The direct determination of phenethylbiguanide-'H binding to mitochondria was complicated by the much greater water solubility of phenethylbiguanide, making it likely that unless the binding were relatively tight, an unknown quantity of bound inhibitor would be removed during the process of washing out the medium trapped in the mitochondrial pellet. In order to determine bound phenethylbiguanide-3H without washing the pellet, a tracer quantity of polyethylene glycol-"4C, molecular weight 4000, which is probably excluded from the intramitochondrial water (8) , was added to the incubation mixture. After centrifugation and removal of the supernatant, the amount of 4C and 3H in the unwashed pellet was determined; from these figures, and from the known amounts of 'H and 14C in the supernatant, correction could be made for extramitochondrial medium trapped in the pellet; the total amount of 'H present in the pellet and finally the 'H bound to the mitochondria could then be calculated. Corrections were made for quenching throughout, using channels ratios, external or internal standards where appropriate.
RESULTS
Potentiation of phenethylbiguanide inhibition by fatty acid-free serum albumin. If albumin potentiates the inhibitory potency of phenethylbiguanide by binding and removing some mitochondrial component such as long chain free fatty acid, the degree of potentiation by albumin should depend on the ratio of albumin to mitochondria, rather than on the absolute concentration of albumin in the medium.
As seen in Fig. 1 , as little as 40 jug of albumin per ml of medium (0.65 m/umoles/ml) significantly potentiated phenethylbiguanide inhibition of pyruvate oxidation by guinea pig heart mitochondria equivalent to 0.22 mg of protein per ml. The potentiating effect of albumin rose asymptomatically to a maximum at about 0.5 mg/ml. 50% of this maximum potentiation was achieved at an albumin concentration of about 0.7 mumoles/ml for this quantity of mitochondria. When one-half the quantity of mitochondria was employed, the same degree of potentiation was achieved with onehalf as much albumin. This relationship was consistent with the hypothesis that a constant amount of mitochondrial free fatty acid was present per milligram of mitochondrial protein, and was probably bound to a limited class of fatty acid binding sites on albumin.
The BSA which has not been extracted with heptaneacetic acid and which contains about 1 mole of fatty acid per mole (10) of albumin was significantly less effective in potentiating the inhibitory effects of phenethylbiguanide. Mitochondria prepared without the use of bacterial proteinase exhibited the same degree of sensitivity to phenethylbiguanide and the same albumin potentiation of phenethylbiguanide effect as did mitochondria prepared with proteinase.
Characteristics of fatty acid reversal of phenethylbiguanide inhibition. Phenethylbiguanide inhibition of pyruvate oxidation could be almost completely prevented by inclusion of stearate :albumin in the preincubation medium before the induction of state 3 1 (Table I and Fig. 2 ). When the stearate: albumin complex was added at zero time (i.e. along with the hexokinase), the inhibi- 1 Metabolic states and respiratory control ratios as defined by Chance and Williams (14) are outlined in the accompanying paper (3) . BSA; bovine serum albumin.
Conditions of incubation were as described in the legend to Fig. 1 except that fatty acid and albumin were varied as described in the (Table I ). Since in this experiment stearate was added with albumin in a ratio of 7:1, the final stearate: albumin ratio at 50%o reversal was 0.9: 1, while near maximal reversal the ratio was 2.2:1. When the initial concentration of albumin was higher (9 x 10-5 mole/liter), proportionately larger amounts of stearate were necessary to reverse phenethylbiguanide inhibition to a comparable extent, and the fatty acid: albumin ratio again approached 2: 1 at the point of near maximal reversal (Table II) . Identical restorative effects on respiratory rate were achieved with palmityl-CoA and oleyl-CoA as substrates when long chain free fatty acids were present along with phenethylbiguanide in the incubation medium.
The prevention and reversal of phenethylbiguanide-induced respiratory inhibition by fatty acid: albumin complexes at ratios below 2: 1 stdggests that long chain free fatty acids may saturate a small number of high affinity mitochondrial bonding sites, since the affinity constant of the tightest binding sites on albumin for stearate is about 108 (9) . Alternatively, the number of binding sites for fatty acid on the mitochondrion may be very large but with an affinity for fatty acid which is lower than that of the tightest albumin sites; in this instance, fatty acid would be bound to only a very small percentage of the total mitochondrial sites, but this small quantity of bound fatty acid would be adequate to produce an alteration in sensitivity to phenethylbiguanide inhibition.
Restoration of respiration to the control rate was easily achieved with stearate when the degree of unmodified phenethylbiguanide inhibition was of the order of 30-40%o (Fig. 3, left) . When the initial inhibition was greater, the control rate of Conditions of incubation were as described in legend to Table I . Concentration of phenethylbiguanide was 8 X 10-6 mole/liter in experiments with oleate (18:1 cis) and elaidate (18:1 trass), and was 6 X 10-6 mole/litex in all other experiments. Control flasks contained 9 X 10-6 M albumin.
Incubations were for 45 min. Note that concentration of fatty acids and albumin was an order of magnitude greater than in experiments described in Table I . In-these experiments, a single flask was used to determine each experimental value. * Fatty acids are designated by chain length: number of double bonds; thus abbreviation for stearate is 18:0.
respiration was reached asymptotically as the concentration of fatty acid increased ( Fig. 3 , left).
Restoration of phenethylbiguanide-inhibited respiration by long chain free fatty acids appeared to be due to a quantitative alteration in sensitivity to the action of the inhibitor, rather than to total loss of susceptibility to inhibition. Thus, by increasing the phenethylbiguanide concentration high enough, it was possible to produce the same degree of inhibition of respiration in the presence of long chain fatty acid as in its absence; i.e., in the presence of free fatty acid, 50%o inhibition was achieved at about 2 X 104 instead of 3-5 X 10-5 M phenethylbiguanide (Fig. 4) . It is of interest that this difference in sensitivity to phenethylbiguanide inhibition with and without added fatty acid is of the same order of magnitude as that between mitochondria incubated in the absence versus the presence of fatty acid-free serum albumin alone ( Influence of fatty acid structure on phenethylbiguanide antagonism. Fatty acid structure was found to influence strongly the effectiveness of fatty acid antagonism to phenethylbiguanide inhibition. As the chain length of the fatty acid diminished, reversal of phenethylbiguanide inhibition became less apparent (Tables II and III) . Concentrations of shorter chain fatty acids equimolar to submaximal concentrations of stearate had less preventive effect on phenethylbiguanide inhibition than longer chain acids (Table III) PEBG-/Q4 x CONCENTRATION (M) FIGURE 4 Phenethylbiguanide (PEBG) inhibition of pyruvate oxidation in the presence and absence of serum albumin and of stearate. Conditions of incubation were identical with those described in Fig. 1 (Table II) .
Metabolic fate of free fatty acids added for reversal of phenethylbiguanide inhibition. Carnitine was found not to be necessary for the fatty acidinduced reversal of phenethylbiguanide inhibition (Fig. 2) and, in fact, had essentially no effect on this phenomenon. Since, in the presence of adenosine triphosphate (ATP), carnitine is obligatory for fatty acid oxidation by guinea pig heart mitochondria (3), as it is for mitochondria from other sources, (11, 12) , the lack of a carnitine requirement for fatty acid antagonism to phenethylbiguanide inhibition strongly suggested that the fatty acid effect did not entail activation or oxidation of the fatty acid. For the same reason, the apparent restoration of respiration by fatty acid in mitochondrial preparations exposed to phenethylbiguanide was not likely to be due to the substitution of fatty acid oxidation for that portion of pyruvate oxidation which has been inhibited by phenethylbiguanide. These hypotheses were confirmed directly by measuring the oxidation of pyruvate-1-14C and -2-14C to 14CO2. From the data in Table IV , it may be seen that with both labeled substrates 14CO2 evolution was restored in parallel with oxygen uptake when phenethylbiguanide inhibition was prevented by fatty acid. When the experiment was repeated under identical conditions but with palmitate-1-_4C replacing the fatty acid, and with unlabeled pyruvate as substrate, the amount of palmitate converted to 14CO2 and to soluble radioactive products in the presence of phenethylbiguanide accounted for less than 1% of the total oxygen uptake, despite the restoration of oxygen uptake to 80% of control values.
Reversal of phenethylbiguanide inhibition by long chain fatty acids in mitochondria from other tissues of guinea pig and rat. Phenethylbiguanideinduced inhibition of pyruvate oxidation by mitochondria from guinea pig skeletal muscle and liver was also prevented by stearate. When 14C.
labeled pyruvate was used, the increase in oxygen uptake by mitochondria from these tissues occurring when phenethylbiguanide inhibition was relieved by stearate was accounted for entirely by the increase in pyruvate oxidation. Long chain free fatty acids also produced a reversal of phenethyl- Incubation conditions were identical with those in legend to Table I , ex cept that fatty acid and albumin additions were made as indicated in the Conditions of incubation were identical with those described in legend to Table I Comparison of long chain fatty acids with dinitrophenol in the protection against phenethylbiguanide inhibition. Since uncoupling agents such as halophenols are known to prevent and to reverse the inhibitory effects of guanidine derivatives on mitochondria (1, 2), it seemed particularly important to determine whether the uncoupling properties of long chain fatty acids (13) were obligatory for their antagonism toward guanidinederivative-induced inhibition.
The respiratory control ratio with pyruvate as substrate is a sensitive indicator of mitochondrial integrity and of the tightness of coupling between oxidation and phosphorylation (14) . The control ratio was markedly lowered in the presence of 2,4-dinitrophenol (DNP), due largely to the increase in state 4 rate (Table V) . With larger amounts of DNP, the respiratory rate in the presence of hexokinase (state 3) fell, as observed by others (13) , and actually became lower than the rate in the absence of hexokinase (state 4). In contrast, the presence of stearate at a concentration of 4 X 10-4 mole/liter and a fatty acid:albumin ratio of 3:1 produced insignificant alterations in state 4 and state 3 respiratory rates for pyruvate with consequent preservation of good control ratios (Table V, experiment-1). Even at a fatty acid concentration of 10 X 10-' mole/liter with a fatty acid: albumin ratio of 4.7: 1, the control ratio fell only moderately, mainly as the result of a small absolute increase in state 4 rate (Table V, experiment 2). It should be recalled that 95%o of the inhibition induced by 6 X 10-5 M phenethylbiguanide could be reversed by a stearate concentration of 6 x 10-5 mole/liter, at a stearate: albumin ratio of 2.6: 1, well below the concentration and fatty acid: albumin ratio which affected respiratory control ratio. Conditions of incubation were identical in all experiments and were the same as in legend for Fig. 1 , except for additions as noted. Flasks without fatty acid all contained 0.7 X 10-4 M fatty acid-free bovine serum albumin. Pi esterified and P :0 ratios were determined as described in Methods. All measurements of respiratory rates and phosphate determinations were carried out in duplicate or triplicate flasks and results averaged for each experimental value.
Phenethylbiguanide alone produced only a minimal effect on the control ratio, since both state 4 and state 3 respiratory rates were reduced to the same extent (Table V, experiment 3). When phenethylbiguanide-inhibited state 3 respiration was restored with DNP, control ratios were lowered to the range induced by DNP alone. In contrast, stearate-induced restoration of phenethylbiguanide-inhibited respiration was consistently accompanied by preservation of control ratios close to the values for uninhibited respiration.
At the concentrations of DNP used in these studies, significant lowering of the P: 0 ratio could not be consistently demonstrated (Table V, experiment 1). P 0 ratios were, however, slightly but reproducibly lowered when substantial respiratory inhibition was induced with phenethylbiguanide alone; when phenethylbiguanide-inhibited respiration was restored with DNP, the P: 0 ratio was not increased to normal (Table V, experiment 3) . Stearate alone did not alter the P: 0 ratio appreciably; reversal of phenethylbiguanide-inhibited respiration by stearate restored the P: 0 ratio toward the control value, in contrast to the lack of effect of DNP (Table V, experiments 1 
and 3).
Inhibition of respiration by other guanidine derivatives: effects of serum albumin and long chain free fatty acids. The inhibitory properties of several other guanidine derivatives of guinea pig heart mitochondrial pyruvate oxidation were also studied. These compounds exhibit some functional specificity in locus of inhibition (1): the monoguanidine derivatives appear to inhibit largely at the first energy conservation site; hence they affect the metabolism of substrates oxidized via pyridine nucleotide-linked reactions. Increasing the chain length of the alkyl substituent of guanidine up to 12 carbons markedly enhances the inhibitory potency but does not appear to affect the locus of action (18) . Phenethylbiguanide, in contrast, appears to affect mainly the second energy conservation site. When the two guanidine residues are separated by increasing numbers of methylene groups, however, the second energy conservation site is much less strongly affected, and inhibition at the third site becomes predominant.
The relative potentiating effect of serum albumin for each inhibitor appeared to vary in exact parallel with the preventive effect of long chain free fatty acid against inhibition by that same Reversal of Guanidine-Derivative Inhibition by Free Fatty Acids FIGURE 5 Inhibition of guinea pig heart mitochondrial respiration by guanidine derivatives in the presence and absence of albumin. Conditions of incubation were as described in legend to Fig. 1 (Fig. 5) , and phenethylbiguanide by 5-600%7o (Fig. 4) . The relative ability of stearate to prevent the inhibition induced by these compounds increased in the same order (Fig. 3, left and right) . It is of interest that, with the exception of decamethylene diguanide, the over-all inhibitory potency of this series of compounds also increased in the same order.
These data indicate that the interaction of fatty acids and guanidine derivatives is not limited to a single energy conservation site. This interaction appears to be governed rather by the structure of the inhibitor, a nonpolar side chain generally increasing the susceptibility of the inhibition to reversal by free fatty acid in addition to enhancing the inhibitory potency (18) .
Binding of long chain free fatty acids to guinea pig heart mitochondria. however, significantly less fatty acid was bound after induction of state 3 than during the preincubation in state 4. When fatty acid-free serum albumin was included in the washing medium, between 40 and 85% of the bound radioactivity was removed in two washes, suggesting that the bulk of the bound fatty acid remained in the unesterified form.
When the bound radioactive lipid was extracted by the method of Bligh and Dyer (15) , chromatographed with carrier lipids on thin-layer plates of silica gel G in a solvent system of petroleum ether-diethyl ether-acetic acid (90: 10: 1), and individual spots eluted with diethyl ether, no radioactivity was detected at the origin where the phospholipids remain. All the radioactivity was found in the spot corresponding to the free fatty acids; total recovery of radioactivity was 60% in this procedure.
Binding of fatty acid was extremely sensitive to the fatty acid: albumin ratio. At low fatty acid: albumin ratios, (5: 1 or less), the amount of fatty acid bound reached an apparent maximum at relatively low concentrations of fatty acid, a fact which suggests saturation of high affinity mitochondrial binding sites (Fig. 6a) . At higher fatty acid: albumin ratios, i.e. 9: 1, binding continued to increase with increasing concentrations (Fig.   6b ). About 10-12 fumoles of stearate were bound per mg of mitochondrial protein under conditions which produced 50% reversal of the inhibition by 4 X 10-5 M phenethylbiguanide (cf. Fig. 3) .
Fatty acid chain length also exerted a strong influence on the magnitude of binding to mitochondria. The quantity of fatty acid bound became progressively less as the chain length decreased, the binding of laurate being only about 5% as great as that of stearate when mitochondria were exposed to equimolar amounts of fatty acid at the same fatty acid: albumin ratio (Fig. 7) . This decrease in mitochondrial binding could not be due to greater binding to serum albumin, since the affinity of serum albumin for fatty acids decreases as the chain length diminishes (9) . These incubations were carried out in state 4 and in the absence of carnitine, making it most unlikely that the differences in recovery of bound radioactivity were due to differential oxidation of the shorter chain acids. The relative magnitude of binding of the different chain length fatty acids closely paralleled the effectiveness of these fatty acids as antagonists of the inhibitory action of phenethylbiguanide (Tables II and III) . Finally, addition of phenethylbiguanide in concentrations up to 103 mole/ STEARATE ADDED, mpmoles FIGURE 6 Binding of stearate-1-"4C to guinea pig heart mitochondria at different fatty acid: albumin ratios. Conditions of incubation were the same as described in the legend to Fig. 1 , except that stearate-1-'4C and fatty acid-free bovine serum albumin were present in the concentrations and ratios indicated. Each flask contained 0.55 mg of mitochondrial protein. Incubations were carried out for 15 min in the absence of hexokinase, the mitochondria centrifuged and washed, and radioactivity determined as described in Methods.
liter was found to cause no detectable alteration in the binding to guinea pig heart mitochondria of stearate-1-14C added as the 1: 1, 2: 1, or 4: 1 fatty acid: albumin complex.
Binding of phenethylbiguanide-3H to guinea pig heart mitochondria. Phenethylbiguanide binding to mitochondria did not appear to reach saturation in the same manner as did the binding of fatty acids, but continued to increase in quantity over the range of concentrations tested. Binding was dependent to some degree on the presence of substrate. The total quantity of phenethylbiguanide bound was less than that of stearate, generally in the range of 2-3 mumoles/mg of mitochondrial protein, at concentrations of phenethylbiguanide in the range which produced about 50%o inhibition of respiration (Fig. 8) .
Most striking, however, was the decrease in binding of phenethylbiguanide to mitochondria in the absence of BSA, an over-all reduction of about 60%o (Fig. 8, left) . The magnitude of this change FIGURE 7 Binding of saturated fatty acids of different chain lengths to guinea pig heart mitochondria. Incubations were carried out under state 4 conditions and radioactivity determined as described in legends to Figs. 1 and 6. Fatty acids, all labeled with '4C in the carboxyl carbon, were added as the fatty acid: albumin complex at a ratio of 2: 1. (Fig. 8, right) .
DISCUSSION
Binding of phenethylbiguanide and the effects of free fatty acids. Diminution of the inhibitory potency of biguanide inhibitors by long chain fatty acids in these studies was obtained under conditions in which the fatty acids exerted no discernable effects on the respiratory rate, P: 0 ratio, or respiratory control. In fact, were it not for the alteration in sensitivity to guanidine-derivative inhibition, there would have been no reason to suspect any functional interaction of long chain free fatty acids with mitochondria under these conditions. In this respect, the current experiments resemble others in which low concentrations of exogenously added free fatty acids (3 x 105 mole/liter) inhibited (32P1) -ATP and P1-H2180 exchange reactions while not affecting basal ATPase activity or causing mitochondrial swelling (16) . Similar low concentrations of exogenous fatty acids prevented the activation of ATPase by DNP (5) . This evidence plus studies of fatty acid-H2180 exchange (17) has been interpreted to mean that the carboxyl group of long chain free fatty acids may interact with the high energy intermediates of mitochondria, possibly undergoing transient covalent bonding with these intermediates. Direct analysis has also established that small amounts of endogenous long chain free fatty acids accumulate in mitochondria, probably as the result of endogenous mitochondrial phospholipase activity; these fatty acids are responsible for the progressive inactivation of DNP-stimulated ATPase which takes place in mouse liver mitochondria during incubation at 370C (4).
In contrast, relatively high concentrations of exogenously added fatty acids (5 x 1O4 mole/ liter) uncouple respiration when added in vitro and in even higher concentrations (2 X 103 mole/ liter) inhibit respiration, probably as the result of the detergent properties of aqueous solutions of fatty acid soaps (13) . The presence of serum albumin in the experiments of the current studies limited the concentration of unbound free fatty acid in solution to the range of 10-7 mole/liter (9) ; it was therefore not surprising that uncoupling or inhibitory effects of fatty acids were not observed.
Fatty acids may bring about the apparent decrease in inhibitory potency of the guanidinederived inhibitors by a number of mechanisms.
(a) Charge neutralization in solution. This possibility is rendered highly unlikely by the kinetics of restoration of respiration when fatty acid is added to an inhibited mitochondrial system (Fig. 2) , since charge neutralization might be expected to occur rapidly and without a lag period. If simple charge neutralization were a significant mechanism, equimolar concentrations of shorter chain fatty acids should have been as effective in preventing guanide-induced inhibition as longer chain acids, and the fatty acid effect should have depended on the absolute fatty acid concentration rather than on the fatty acid: albumin ratio; neither of these effects was observed.
( (Fig. 8) . Not only is the magnitude of this decrease sufficient to explain most of the difference in inhibition, but also bound fatty acid might be expected actually to increase the amount of bound phenethylbiguanide if electrostatic interactions on the surface of the mitochondrion were involved in the fatty acid-induced change in inhibitory potency of the biguanide.
(d) Alteration by fatty acids of the number of binding sites for guanidine derivatives. The reversal of phenethylbiguanide inhibition by DNP has been taken as evidence that guanidine-derived inhibitors bind to "high energy intermediates" (1, Reversal of Guanidine-Derivative Inhibition by Free Fatty Acids 2, 18), since it is also generally assumed that DNP allows dissipation of these high energy intermediates. In this scheme, the interference by DNP with biguanide-induced inhibition would be explained by a diminution in the number of biguanide binding sites. Since under the conditions of the current experiments long chain free fatty acids induced no discernible changes in the creation or dissipation of such high energy intermediates, an analogous hypothesis does not seem likely to explain the fatty acid effect.
It is worth pointing out that some kinetic evidence does not support the concept that DNP allows "dissipation" of high energy intermediates (19) but rather may prevent their formation. In addition, Dicoumarol, despite its considerable activity as an uncoupler, does not reverse the inhibition induced by octylguanidine, whereas DNP does, an observation which has been interpreted to indicate energy conservation site specificity of the uncouplers (2) . However, these data can also be taken simply as a further demonstration of a more general dissociation of uncoupling activity from the ability to reverse guanidine-derivative inhibition; octyldinitrophenol, which is six times more potent as an uncoupler than is DNP itself, resembles Dicoumarol in its inability to reverse octylguanidine inhibition (2) . Finally, the lag period observed during the reversal of biguanide-induced inhibition by DNP has previously been attributed to a "position effect" of the sites of action of these two compounds in relation to the electron' transport chain (18) . The resemblance of the DNP lag period to that seen with fatty acid-induced reversal of inhibition, however, suggests that the two compounds may both affect biguanide inhibition by similar mechanisms, and that this ability to reverse guanidine-derivative inhibition may not be directly related to uncoupling activity.
( (20) , long chain fatty acylCoA derivatives (21) , and citric acid cycle intermediates (22) (23) (24) . This rate-limiting barrier may constitute a major site of control for the rate of lipogenesis (25, 26) , gluconeogenesis (22) , and glycolysis (27) through control of the flux of citrate, a-ketoglutarate, and amino acids into the cytoplasmic compartment. Several experimental observations suggest that exogenous fatty acids, introduced into the medium bound to albumin, or endogenous fatty acids, may increase the permeability of mitochondrial membranes to long chain fatty acyl-CoA substrates (28) and to Mg++ (29) . The stimulation of gluconeogenesis (30) and inhibition of glycolysis (27) produced by long chain fatty acids in perfusion studies may in part be explained by such effects on mitochondrial permeability. The current binding experiments with phenethylbiguanide-3H support the role of long chain free fatty acids in altering the accessibility of intramitochondrial spaces to certain small molecules.
Conversely, as suggested in the preceding paper (3), the mechanism whereby the guanidine derivatives lower the blood sugar may well relate to their ability to alter the transmembrane flux of these same metabolic intermediates, but in a manner opposite to the changes induced by free fatty acids. In this respect, the guanidine derivatives may resemble hypoglycin (L-a-amino-,8-methylenecyclopropane propionic acid), the hypoglycemic activity of which has been postulated to result from inhibition of the palmityl-CoA:carnitine acyltransferase reaction (31) in hepatic mitochondria, with consequent restriction of gluconeogenesis. Butylbiguanide, in concentrations too low to interfere with respiration, has been shown to inhibit the efflux of amino acids, K+, Pi, and urea from isolated, perfused rat liver (32) , and octylguanidine interferes with the efflux of K+ from rat liver mitochondria induced in vitro by histones (33) . In a functional sense, then, guanidine derivatives may be free fatty acid antagonists at a mitochondrial level. It is possible that the differences in sensitivity of diabetic versus nondiabetic humans to the hypoglycemic activity of these agents may spring at least in part from differences in the tissue levels of free fatty acids or in the sensitivity of mitochondria to the effects of these fatty acids.
It should be emphasized that the possible existence of guanidine derivative-sensitive transmitochondrial membrane metabolite transfer does not rule out an independent, direct inhibitory effect of guanidine derivatives on electron transport or energy conservation, as suggested by previous work (2, 18) . Rupture of the intact mitochondrion might be expected to eliminate the "permeability" component of guanidine derivatives inhibition while not affecting the "energy conservation" component of inhibition. Such "tightly coupled" submitochondrial particles have been found to be susceptible to respiratory inhibition by phenethylbiguanide and octylguanidine; DNP was no longer capable of reversing inhibition (34) in these particles, however, consistent with the hypothesis that the major effect of DNP in intact mitochondria may be on the "permeability" inhibition by biguanides.
